Search
for
Sort by
Research 721–750 of 1000+
- Novel drugs of United States Food and Drug Administration approved in 2024
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Notes from the Editor Emeritus
- Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review
- Update on the pathogenesis, genetics and medical treatment of patterned hair loss.
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Endocrine disorders and hormonal therapy for adolescent acne
- Biologics in the management of childhood atopic dermatitis
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Updates in Vitiligo
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review
- Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries
- From flint razors to lasers: a timeline of hair removal methods
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Up in smoke: A neurologist's approach to “medical marijuana”
- Understanding Pattern Hair Loss—Hair Biology Impacted by Genes, Androgens, Prostaglandins and Epigenetic Factors
- Lipolytic agents for submental fat reduction: Review
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- A Scoping Review of Pharmacotherapy, Complementary, and Alternative Medicine (CAM), and Surgical Therapies for Androgenic Alopecia
- Pharmacological Treatment of Alopecia
- Hair Physiology (Hair Growth, Alopecia, Scalp Treatment, etc.)
- Editorial Comment
- Non-pharmacological therapies in the treatment of chemotherapy-induced alopecia – a literature review
- How to treat androgenetic alopecia – the most common form of hair loss. A review
- Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia
- Updated Review of Treatment of Androgenetic Alopecia